Inventor · disambiguated record
Jennifer D. Hamilton
Also filed as: HAMILTON JENNIFER · HAMILTON JENNIFER D · HAMILTON JENNIFER DAVIDSON
11 granted patents·12 pending applications·111 citations·filing 2013–2023
89Inventor score
Top patents by PatentIndex Score
23 records- 0194US10066017B2Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonistSANOFI BIOTECHNOLOGY·Filed 2015·Granted Sep 4, 2018·25 cites·33 claims
- 0293US9574004B2Methods for treating or preventing asthma by administering an IL-4R antagonistSANOFI SA·Filed 2013·Granted Feb 21, 2017·44 cites·19 claims
- 0392US10370449B2Methods for treating skin infection by administering an IL-4R antagonistREGENERON PHARMA·Filed 2015·Granted Aug 6, 2019·16 cites·21 claims
- 0491US11053309B2Methods for treating active eosinophilic esophagitisREGENERON PHARMA·Filed 2018·Granted Jul 6, 2021·12 cites·22 claims
- 0587US11845800B2Methods for treating or preventing asthma by administering an IL-4R antagonistSANOFI BIOTECHNOLOGY·Filed 2017·Granted Dec 19, 2023·4 cites·33 claims
- 0684US11999777B2Methods for treating or preventing SARS-CoV-2 infections and COVID-19 with anti-SARS-CoV-2 spike glycoprotein antibodiesREGENERON PHARMA·Filed 2021·Granted Jun 4, 2024·2 cites·68 claims
- 0784US11771743B2Methods for preventing or treating allergy by administering an IL-4R antagonistREGENERON PHARMA·Filed 2017·Granted Oct 3, 2023·5 cites·15 claims
- 0884US11214621B2Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonistSANOFI BIOTECHNOLOGY·Filed 2018·Granted Jan 4, 2022·2 cites·39 claims
- 0980US2024199751A1Methods for treating or preventing asthma by administering an il-4r antagonistSANOFI BIOTECHNOLOGY·Filed 2023·Application pending·0 cites
- 1077US11504426B2Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonistREGENERON PHARMA·Filed 2020·Granted Nov 22, 2022·1 cites·28 claims
- 1174US2023357416A1Methods for treating skin infection by administering an il-4r antagonistREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1273US12502429B2Methods for treating atopic dermatitis by administering an IL-4R antagonistREGENERON PHARMA·Filed 2022·Granted Dec 23, 2025·0 cites·42 claims
- 1371US11603408B2Methods for treating skin infection by administering an IL-4R antagonistREGENERAN PHARMACEUTICALS INC·Filed 2019·Granted Mar 14, 2023·0 cites·17 claims
- 1469US2022204631A1Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonistSANOFI BIOTECHNOLOGY·Filed 2021·Application pending·0 cites
- 1568US2024082353A1Methods for preventing or treating allergy by administering an il-4r antagonistREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1663US2021363237A1Methods for treating active eosinophilic esophagitisREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 1762US2023293682A1Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an il-4r antagonistREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 1857US2023416349A1Methods Of Identifying And Evaluating Cat Allergy Gene Signatures In A Subject By Determining A Stratified Score Based On Gene ExpressionREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1956US2023340601A1Transcriptome Analysis For Treating InflammationREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2056US2024034798A1Methods for treating eosinophilic esophagitis by administering an il-4r antagonistREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2152US2014072583A1Methods for treating atopic dermatitis by administering an il-4r antagonistREGENERON PHARMA·Filed 2013·Application pending·0 cites
- 2249US2017333557A1Methods for Treating Atopic Dermatitis by Administering an IL-4R AntagonistREGENERON PHARMA·Filed 2017·Application pending·0 cites
- 2346US2025154267A2Methods for treating eosinophilic esophagitis by administering an il-4r inhibitorREGENERON PHARMA·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jennifer D. Hamilton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →